Diabetes Trial Files
Subscribe
Sign in
Home
Archive
About
Latest
Top
Diabetes Trial Files Throwback Thursday: Intensive BP Control in T2DM, Metformin and Intensive Lifestyle in Prediabetes, and CABG vs. PCI…
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
Jun 12
Share this post
Diabetes Trial Files
Diabetes Trial Files Throwback Thursday: Intensive BP Control in T2DM, Metformin and Intensive Lifestyle in Prediabetes, and CABG vs. PCI for CAD in T2DM
Copy link
Facebook
Email
Notes
More
May 2025
Diabetes Trial Files: Tirzepatide for Obesity + Prediabetes, Tirzepatide in HF + Obesity, and Switching from Dulaglutide to Tirzepatide
Tirzepatide for Obesity Treatment and Diabetes Prevention
May 15
Share this post
Diabetes Trial Files
Diabetes Trial Files: Tirzepatide for Obesity + Prediabetes, Tirzepatide in HF + Obesity, and Switching from Dulaglutide to Tirzepatide
Copy link
Facebook
Email
Notes
More
April 2025
Diabetes Trial Files Throwback Thursday: Liraglutide and CVD Endpoints in T2DM, Basal-bolus Insulin in T2DM, and ACE+ARB in DM Nephropathy
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Apr 17
Share this post
Diabetes Trial Files
Diabetes Trial Files Throwback Thursday: Liraglutide and CVD Endpoints in T2DM, Basal-bolus Insulin in T2DM, and ACE+ARB in DM Nephropathy
Copy link
Facebook
Email
Notes
More
March 2025
Diabetes Trial Files: Semaglutide for Cardiac Function in Obesity-Related HFpEF, Dapagliflozin + Calorie Restriction for T2DM Remission, and…
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure
Mar 20
Share this post
Diabetes Trial Files
Diabetes Trial Files: Semaglutide for Cardiac Function in Obesity-Related HFpEF, Dapagliflozin + Calorie Restriction for T2DM Remission, and Dapagliflozin and Linagliptin in T2DM
Copy link
Facebook
Email
Notes
More
February 2025
Diabetes Trial Files Throwback Thursday: Ramipril vs. Telmisartan vs. Both in CVD, Stroke, PAD, or DM, Intensive Glycemic Therapy in T2DM…
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
Feb 20
Share this post
Diabetes Trial Files
Diabetes Trial Files Throwback Thursday: Ramipril vs. Telmisartan vs. Both in CVD, Stroke, PAD, or DM, Intensive Glycemic Therapy in T2DM, and Canagliflozin in Diabetic Nephropathy
Copy link
Facebook
Email
Notes
More
January 2025
Diabetes Trial Files: A Metabolic Intervention Regimen vs. Standard Care for T2DM Remission, Inhaled TI + Insulin Degludec in T1DM, and…
Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide
Jan 23
Share this post
Diabetes Trial Files
Diabetes Trial Files: A Metabolic Intervention Regimen vs. Standard Care for T2DM Remission, Inhaled TI + Insulin Degludec in T1DM, and Cotadutide in T2DM & CKD
Copy link
Facebook
Email
Notes
More
December 2024
Diabetes Trial Files Throwback Thursday: Empa for CV outcomes in T2DM, ARBs in Diabetic Nephropathy, and GLP-1 in T2DM & High CVD Risk
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Dec 26, 2024
Share this post
Diabetes Trial Files
Diabetes Trial Files Throwback Thursday: Empa for CV outcomes in T2DM, ARBs in Diabetic Nephropathy, and GLP-1 in T2DM & High CVD Risk
Copy link
Facebook
Email
Notes
More
November 2024
Diabetes Trial Files: The Intense Simplified Strategy for T2DM, Semaglutide in Obesity + Osteoarthritis, and Liraglutide for Children with…
Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia
Nov 28, 2024
Share this post
Diabetes Trial Files
Diabetes Trial Files: The Intense Simplified Strategy for T2DM, Semaglutide in Obesity + Osteoarthritis, and Liraglutide for Children with Obesity
Copy link
Facebook
Email
Notes
More
October 2024
Diabetes Trial Files Throwback Thursday: Canagliflozin for T2DM, Intensive vs. Standard Glucose Lowering Therapy, and Renoprotective Effect…
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Oct 31, 2024
Share this post
Diabetes Trial Files
Diabetes Trial Files Throwback Thursday: Canagliflozin for T2DM, Intensive vs. Standard Glucose Lowering Therapy, and Renoprotective Effect of Irbesartan
Copy link
Facebook
Email
Notes
More
Diabetes Trial Files: GEMI + DAPA Add-On in T2DM, Triple Combination Therapy, and Semaglutide in CKD & T2DM
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone (SOLUTION 2)
Oct 3, 2024
Share this post
Diabetes Trial Files
Diabetes Trial Files: GEMI + DAPA Add-On in T2DM, Triple Combination Therapy, and Semaglutide in CKD & T2DM
Copy link
Facebook
Email
Notes
More
September 2024
Diabetes Trial Files Throwback Thursday: Weight Loss & Exercise in T2DM, Darbepoetin in CKD & T2DM, and Metformin in T2DM
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
Sep 5, 2024
Share this post
Diabetes Trial Files
Diabetes Trial Files Throwback Thursday: Weight Loss & Exercise in T2DM, Darbepoetin in CKD & T2DM, and Metformin in T2DM
Copy link
Facebook
Email
Notes
More
August 2024
Diabetes Trial Files: Empa on Ventricular Arrhythmias in T2DM, Semaglutide for CKD in T2DM, and Tirzepatide vs. Insulin Glargine
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator (EMPA-ICD)
Aug 8, 2024
Share this post
Diabetes Trial Files
Diabetes Trial Files: Empa on Ventricular Arrhythmias in T2DM, Semaglutide for CKD in T2DM, and Tirzepatide vs. Insulin Glargine
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts